The question every FTCA11 unitholder is asking right now is simple: is the R$ 0.093 dividend a sign of structural deterioration or a one-off adjustment? Based on the June 2026 management report and the official filings on B3 (Brazil's stock exchange), the answer is that it is a one-off accounting adjustment — not a new default. The distribution fell because the fund's manager was required to recognize, within the month's results, the mark-to-market (MtM) effect on its two already-known delinquent credits: the Castilhos CRA and the Cotribá CRI. No new credit turned sour in June. What happened was the fund pulling a latent portfolio loss into the distributable income line.
That said, the episode is not trivial. The -7.76% intraday collapse — from R$ 8.12 to R$ 7.49 — signals that the market read the cut as confirmation that the Castilhos resolution timeline just got longer. When the farm auction ended with zero bidders, the clearest near-term catalyst for unlocking value disappeared. What remains is private negotiation, which moves slower and offers no clear deadline. Today's price is the market demanding a steeper discount to hold that open-ended credit risk. And the discount reached its widest point in the fund's history.
FTCA11 is the Fyto Recebíveis do Agronegócio fund, a Brazilian Fiagro (FII — Brazilian REIT — focused on agribusiness credit) managed by Fyto Capital Administradora de Recursos and administered by BTG Pactual Serviços Financeiros DTVM. The fund holds R$ 46.97 million in net assets, 4,459,952 shares, and 7,672 unitholders (May 2026 data). One detail worth noting upfront: the manager is the former NCH Brasil, which was before that EQI — three rebrands in four years. Institutional instability tends to track strategic instability.
What Is Mark-to-Market (MtM) and Why Did It Cut the Dividend?
A Fiagro like FTCA11 holds a basket of CRAs (Certificados de Recebíveis do Agronegócio — Brazilian agribusiness receivable certificates, essentially bonds where agro companies borrow and pay interest) and some CRIs (the real-estate equivalent). The fund operates under accrual accounting: the monthly result reflects the economic value the portfolio generated, not just the cash received.
Mark-to-market (MtM) is the process of repricing each security at its current fair value rather than face value. When a CRA is delinquent and the probability of collection drops, its fair value shrinks. That reduction flows through the income statement as a paper loss — and since the distribution is drawn from net income, the dividend falls with it. That is precisely what happened in June: MtM adjustments on the problem credits consumed part of the distributable income and pushed the dividend from ~R$ 0.11-0.12 down to R$ 0.093/share (a 22% cut), payable July 23, 2026, tax-exempt for Brazilian individual investors. Monthly yield slid to 113% of the CDI (Brazil's interbank overnight rate, used as the risk-free benchmark), against the 140%–160% of CDI range seen in prior months.
In plain English: unitholders received less not because a new borrower defaulted in June, but because the fund adjusted the carrying value of debts that were already impaired. The difference between "the wound got worse" and "the doctor finally measured it properly." The wound — Castilhos and Cotribá — is the same.
Dividend History: Putting the Cut in Context
June's cut did not come out of nowhere. The distribution has been drifting lower since early 2026 as the manager shifted to a more defensive posture. The table below uses an estimated CDI annual rate of R$ 13.65 per unit to compute the monthly payout as a percentage of the risk-free benchmark.
| Month | R$/share | M/M change | % of CDI (est.) |
|---|---|---|---|
| Oct/25 | 0.140 | — | 123% |
| Nov/25 | 0.135 | -3.6% | 119% |
| Dec/25 | 0.130 | -3.7% | 114% |
| Jan/26 | 0.130 | 0.0% | 114% |
| Feb/26 | 0.120 | -7.7% | 106% |
| Mar/26 | 0.110 | -8.3% | 97% |
| Apr/26 | 0.110 | 0.0% | 97% |
| May/26 | 0.110 | 0.0% | 97% |
| Jun/26 | 0.093 | -15.5% | 82% |
The CDI percentage above is calculated against the fund's net asset value. At today's market price of R$ 7.49 — far below the NAV — the same R$ 0.093 distribution actually yields 113% of CDI on a cost basis. The discount in the share price "rescues" the running yield: buyers at the depressed price receive proportionally more yield per real invested.
Castilhos: Failed Auction — How Bad Is It, Really?
The Castilhos CRA (CETIP code CRA021001VB) is the fund's largest headache: it represents 5.71% of NAV, roughly R$ 2.67 million, backed by grain farms in Bahia, Brazil. The paper is delinquent and in June 2026 the public auction of those farms ended with zero bidders — not a single buyer showed up. Fyto Capital stated the result "came as no surprise" and the process moves to private negotiation.
A deserted auction sounds alarming but requires context. No bidder at a public auction does not mean the asset is worthless. Large-scale farmland in Bahia's interior attracts a very narrow universe of qualified buyers; a forced auction — short notice, full cash payment required, generic advertising — rarely finds the right counterpart. The manager had already discounted this CRA by 40% from face value and maintained that discount after the auction, without an additional negative mark. In other words: the worst was already in the price. The path forward is a private sale, which is slower (no set deadline) but historically captures better value than a forced liquidation.
And here is the point the market appears to be overlooking when punishing the share price. A full recovery would reverse the 40% discount applied to 5.71% of NAV. Running the numbers: 40% of R$ 2.67 million is roughly R$ 1.07 million of direct accounting gain; full recovery of the outstanding balance could deliver close to R$ 0.60 per share in recoverable book value under the most favorable scenario. For a fund trading at R$ 7.49, that is enormous — nearly 8% of the current price hinging on a single credit.
| Castilhos Recovery Scenario | Amount | Gain approx./share |
|---|---|---|
| Reversal of 40% discount | ~R$ 1.07M | ~R$ 0.24 |
| Partial recovery | ~R$ 1.8M | ~R$ 0.40 |
| Full recovery of outstanding balance | ~R$ 2.67M | ~R$ 0.60 |
Cotribá: The Slow Bleed of Stop Accrual
The second problem credit is the Cotribá CRI (2.58% of NAV), backed by a cooperative from Rio Grande do Sul. This asset is on stop accrual — meaning the fund has stopped recognizing interest income on it because the probability of receiving that interest fell too low to justify booking it as profit. While a normal credit drips interest into results every month, a stop-accrual credit goes dry. The situation worsened: the cooperative's judicial recovery request (RJ) was rejected at the appellate level, pushing resolution into an even murkier timeline. In practice, Cotribá no longer contributes the few centavos per share per month it would generate if performing — additional drag on the distribution.
The 32.4% Cash Position: Why the Manager Is Holding Back
A striking number in the report: 32.4% of the fund sits in cash (R$ 15.2 million). That is an extraordinarily defensive posture for a credit-oriented Fiagro. The portfolio breaks down as 59.27% performing credits, 8.29% delinquent, and that one-third sitting idle in liquid instruments. Why?
Because the manager faces a classic credit fund dilemma. It could deploy the cash to boost distributions and keep the dividend at a higher level — pleasing unitholders in the short run. But that would mean distributing capital that may later need to be replenished, should a new credit event arise or additional provisioning be required. The alternative chosen — hold the cash — means lower distributions now but a larger safety buffer. With two open delinquency cases and Castilhos unresolved, keeping dry powder is the conservative call. Short-term investors pay the price of prudence; those with an 18-month horizon tend to prefer the fund with reserves.
The portfolio's structure is worth noting: 90.8% of assets are indexed to CDI+ (average rate CDI+4.96%) and 9.2% to IPCA+ (IPCA+7.82%, where IPCA is Brazil's official inflation index), with a short duration of 1.15 years on performing credits. A short-duration, floating-rate portfolio reprices quickly — but it depends entirely on the creditworthiness of its debtors, which is exactly where today's risk sits.
What Unitholders Are Saying
Sentiment among unitholders on the ClubeFII forum mirrors the split between panic and opportunism. One investor reported buying on the dip: "the share is melting!! I checked if there was a rights offering... found nothing, so I bought some! Hoping it's just a seller disappointed with the dividend." Another offered the technical read after studying the report: "huge cash position given current market risk. Accrual basis — the distributable income was affected by the MtM adjustment. The Castilhos case keeps dragging." And, almost prophetically a few days earlier, a third unitholder had warned: "R$ 0.093 tax-exempt!!! Payment July 23, 2026... I think the price is going to fall." Fyto Capital itself scheduled a live investor presentation of the report for today, July 21, 2026, and the market remains cautious pending the formal update post-broadcast.
P/NAV of 0.71: What the Discount Is Pricing
P/NAV (price-to-net-asset-value, equivalent to P/VP in Portuguese) measures how much the market pays per real of the fund's net worth. With NAV per share at R$ 10.51 and the market price at R$ 7.49, P/NAV sits at 0.71 — the market pays just 71 cents for every R$ 1.00 of assets, a 29% discount. The right question is not "is the discount big?" but "does this discount compensate for how much credit risk remains inside?". Embedded in that R$ 10.51 NAV are the Castilhos CRA (40% discounted, 5.71% of NAV) and Cotribá on stop accrual — together roughly 8% of NAV that the market prices as worth even less than the fund's own marks. If Fyto's impairment estimates are correct, there is a margin of safety; if they are understated, the discount is justified.
What Now? Three Scenarios
Bull case: Castilhos is resolved via private negotiation with partial reversal of the 40% discount, and the cash is redeployed into new performing credits. Monthly distribution recovers to ~R$ 0.12 and the share price gravitates back toward R$ 9.50–10.00, closing most of the NAV gap.
Base case: Castilhos is partially resolved with no major positive surprise, and the distribution stabilizes around R$ 0.10–0.11. The share price trades in the R$ 8.00–8.50 range while the market waits for confirmation before repricing.
Bear case: A new credit event in the portfolio compounds a disappointing Castilhos outcome. The distribution stays under pressure and the share tests support below R$ 7.00.
The next few months hinge on two variables: progress on the Castilhos private sale and how management allocates the 32.4% cash hoard. Until Castilhos has a timeline, the 29% NAV discount is likely to persist. This is not a buy or sell recommendation — it is a map of what drives the price.
This content is informational and educational analysis, not an investment recommendation. Buy and sell decisions are the investor's sole responsibility. Data sourced from the June 2026 Management Report (FundosNET/B3, ID 1252768) and the Dividend Notice (FundosNET/B3, ID 1251237).
